Tag: Neurodegenerative Diseases

Sanofi Snags Vigil Neuroscience for Alzheimer's DrugSo, like, Sanofi, the French drug maker, just dropped $470 million to acquire Vigil Neuroscience, a small biotech company. And get this, they're adding an experimental treatment for...

The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be no more effective than a placebo in a large clinical...

The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known as Kisunla, has raised concerns about its accessibility to patients....

Dementia is a growing concern, and Mayo Clinic researchers believe that artificial intelligence (AI) can help with faster and earlier diagnoses. By combining AI with EEG tests, the Mayo Clinic Neurology AI Program (NAIP)...

Scientists have recently made a significant advancement in the quest for a simple blood test to accurately diagnose Alzheimer's disease. The study, published in the journal JAMA, revealed that the blood test was approximately...